Biomarkers play a key role in every aspect of personalized healthcare innovation, from assessing target inhibition, testing the mechanism, to supporting dose selection, trial design and identification of the patients most likely to respond. Biomarker strategies supporting the clinical development of novel therapeutics in ophthalmology, metabolism, neuroscience, immunology and infectious diseases will be discussed.